Cancer Communications | Home page

Cancer Communications | Home page

Cancer Communications

Affiliated with

• 
• 
• Cancer Communications is affiliated with Chinese Anti-Cancer Association and US Chinese Anti-Cancer Association.

Articles

• Recent
• Most accessed
• Collections

1. Content Type:Editorial

     |  25 June 2019

   Induction gemcitabine and cisplatin in locoregionally advanced nasopharyngeal carcinoma

   Authors:Yuan Zhang, Ying Sun and Jun Ma
2. Content Type:Original Article

     |  24 June 2019

   Pertuzumab in combination with trastuzumab and chemotherapy for Chinese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subpopulation analysis of the JACOB trial

   Authors:Tianshu Liu, Yanru Qin, Jin Li, Ruihua Xu, Jianming Xu, Shujun Yang, Shukui Qin, Yuxian Bai, Changping Wu, Yixiang Mao, Haiyan Wu, Yilin Ge and Lin Shen
3. Content Type:Letter To The Editor

     |  21 June 2019

   Somatic mutations in renal cell carcinomas from Chinese patients revealed by targeted gene panel sequencing and their associations with prognosis and PD-L1 expression

   Authors:Jie Wang, Jianzhong Xi, Hanshuo Zhang, Juan Li, Yuchao Xia, Ruibin Xi and Zhijun Xi
4. Content Type:Review

     |  20 June 2019

   China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non-small cell lung cancer after two lines of chemotherapy

   Authors:Ming Zhou, Xiaoyuan Chen, Hong Zhang, Lin Xia, Xin Tong, Limin Zou, Ruimin Hao, Jianhong Pan, Xiao Zhao, Dongmei Chen, Yuanyuan Song, Yueli Qi, Ling Tang, Zhifang Liu, Rong Gao, Yuankai Shi…
5. Content Type:Letter To The Editor

     |  19 June 2019

   Microscopic tumor foci in axillary lymph nodes may reveal the recurrence dynamics of breast cancer

   Authors:Romano Demicheli, Marco Fornili, Patrizia Querzoli, Massimo Pedriali, Saverio Alberti, Christine Desmedt and Elia Biganzoli